Clinical Trial Update: Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes resiniferatoxin being investigated to treat severe pain in patients with advanced cancer, with the study currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Resiniferatoxin (resiniferatoxin)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Intractable Pain, Palliative Care | Phase 1 | Status: RECRUITING